[HTML][HTML] Detection of tumor NTRK gene fusions to identify patients who may benefit from tyrosine kinase (TRK) inhibitor therapy

SJ Hsiao, A Zehir, AN Sireci, DL Aisner - The Journal of Molecular …, 2019 - Elsevier
Chromosomal rearrangements involving the NTRK1, NTRK2, and NTRK3 genes (NTRK
genes), which encode the high-affinity nerve growth factor receptor (TRKA), brain-derived …

The role of molecular testing in the differential diagnosis of salivary gland carcinomas

A Skálová, G Stenman, RHW Simpson… - The American journal …, 2018 - journals.lww.com
Salivary gland neoplasms are a morphologically heterogenous group of lesions that are
often diagnostically challenging. In recent years, considerable progress in salivary gland …

Management of salivary gland malignancy: ASCO guideline

JL Geiger, N Ismaila, B Beadle, JJ Caudell… - Journal of Clinical …, 2021 - ascopubs.org
PURPOSE To provide evidence-based recommendations for practicing physicians and
other healthcare providers on the management of salivary gland malignancy. METHODS …

[HTML][HTML] Salivary gland carcinoma: novel targets to overcome treatment resistance in advanced disease

L Di Villeneuve, IL Souza, FDS Tolentino… - Frontiers in …, 2020 - frontiersin.org
Salivary gland carcinomas (SGC) account for less than 5% of head and neck malignant
neoplasms, further subcategorized in over 20 histological subtypes. For the most part …

[HTML][HTML] RET signaling pathway and RET inhibitors in human cancer

AT Regua, M Najjar, HW Lo - Frontiers in Oncology, 2022 - frontiersin.org
Rearranged during transfection (RET) receptor tyrosine kinase was first identified over thirty
years ago as a novel transforming gene. Since its discovery and subsequent pathway …

Nuclear NR4A3 immunostaining is a specific and sensitive novel marker for acinic cell carcinoma of the salivary glands

F Haller, A Skálová, S Ihrler, B Märkl… - The American journal …, 2019 - journals.lww.com
Recently, we discovered the recurrent genomic rearrangement [t (4; 9)(q13; q31)] enabling
upregulation of the transcription factor Nuclear Receptor Subfamily 4 Group A Member 3 …

High-grade transformation/dedifferentiation in salivary gland carcinomas: occurrence across subtypes and clinical significance

A Skalova, I Leivo, H Hellquist, A Agaimy… - Advances in anatomic …, 2021 - journals.lww.com
High-grade transformation (HGT) or dedifferentiation has been described in a variety of
salivary gland carcinomas, including acinic cell carcinoma, secretory carcinoma, adenoid …

Expanding the molecular spectrum of secretory carcinoma of salivary glands with a novel VIM-RET fusion

A Skálová, M Baneckova, LDR Thompson… - The American Journal …, 2020 - journals.lww.com
Background: Secretory carcinoma (SC), originally described as mammary analogue SC, is a
predominantly low-grade salivary gland neoplasm characterized by a recurrent t (12; …

Molecular profiling of salivary gland intraductal carcinoma revealed a subset of tumors harboring NCOA4-RET and novel TRIM27-RET fusions: a report of 17 cases

A Skálová, T Vanecek, E Uro-Coste… - The American journal …, 2018 - journals.lww.com
Intraductal carcinoma (IC) is the new World Health Organization designation for tumors
previously called “low-grade cribriform cystadenocarcinoma” and “low-grade salivary duct …

Molecular profiling of clear cell myoepithelial carcinoma of salivary glands with EWSR1 rearrangement identifies frequent PLAG1 gene fusions but no EWSR1 fusion …

A Skálová, A Agaimy, T Vanecek… - The American Journal …, 2021 - journals.lww.com
Myoepithelial carcinoma of salivary glands is an underrecognized and challenging entity
with a broad morphologic spectrum, including an EWSR1-rearranged clear cell variant …